PTC Therapeutics, Inc. (PTCT): Brookside Capital Ups Exposure in a Profitable Investment

In a new filing with the Securities and Exchange Commission, Bain Capital's Brookside Capital disclosed increasing its activist stake in PTC Therapeutics, Inc. (NASDAQ:PTCT).

Keep Reading →